搜尋結果
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
Reuters· 4 小時前... discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical ...
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Reuters· 9 小時前, opens new tab raised its 2024 outlook on Thursday as the Danish drugmaker races to boost ...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 2 日前Eli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher ...
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 3 日前... challenging hundreds of alleged “junk” patent listings filed by several pharmaceutical ... ...
Global Inequities In Access To Drugs Costs Millions Of Lives Each Year
Forbes· 5 日前The World Health Organization estimates that at least one-third of the world’s population does ...